( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
9911.42
8065.71
8381.78
10116.14
Total Expenditure
8519.96
6929.5
7290.59
8837.21
PBIDT (Excl OI)
1391.46
1136.21
1091.19
1278.93
Other Income
108.63
166.52
144.38
232.07
Operating Profit
1500.09
1302.73
1235.57
1511
Interest
374.58
372.87
420.08
370.17
Exceptional Items
NA
NA
NA
NA
PBDT
1125.51
929.86
815.49
1140.83
Depreciation
155.06
157.58
141.26
161.49
Profit Before Tax
970.45
772.28
674.23
979.34
Tax
246.58
210.67
160.85
255.46
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
723.87
561.61
513.38
723.88
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
723.87
561.61
513.38
723.88
Minority Interest
17.26
18.29
18.41
17.13
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
741.13
579.9
531.79
741.01
Equity Capital
871.02
871.02
871.02
871.02
Calculated EPS
4.25
3.32
3.05
4.25
Calculated EPS (Annualised)
17.01
13.31
12.21
17.01
No of Public Share Holdings
31258051
31258051
31258051
31258051
% of Public Share Holdings
17.94
17.94
17.94
17.94
PBIDTM% (Excl OI)
14.03
14.08
13.01
12.64
PBIDTM%
15.13
16.15
14.74
14.93
PBDTM%
11.35
11.52
9.72
11.27